Gilder Gagnon Howe & CO LLC Quanterix Corp Transaction History

Gilder Gagnon Howe & CO LLC

$7.87 Billion
Q3 2024

A detailed history of Gilder Gagnon Howe & CO LLC transactions in Quanterix Corp stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 472,280 shares of QTRX stock, worth $5.56 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

472,280

Previous 932,799 49.37%

Holding current value

$5.56 Million

Previous $12.3 Million 50.37%

% of portfolio

0.08%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.92 - $16.36 $5.03 Million - $7.53 Million	-460,519 Reduced 49.37%	472,280 $6.12 Million
Q2 2024 Aug 14, 2024	SELL	$12.26 - $23.78 $2.96 Million - $5.73 Million	-241,119 Reduced 20.54%	932,799 $12.3 Million
Q1 2024 May 15, 2024	SELL	$21.9 - $28.28 $623,931 - $805,697	-28,490 Reduced 2.37%	1,173,918 $27.7 Million
Q4 2023 Feb 14, 2024	SELL	$19.54 - $28.66 $464,993 - $682,022	-23,797 Reduced 1.94%	1,202,408 $32.9 Million
Q3 2023 Nov 14, 2023	SELL	$21.15 - $27.96 $888,236 - $1.17 Million	-41,997 Reduced 3.31%	1,226,205 $33.3 Million
Q2 2023 Aug 14, 2023	BUY	$11.16 - $23.65 $4.21 Million - $8.93 Million	377,538 Added 42.39%	1,268,202 $28.6 Million
Q1 2023 May 15, 2023	SELL	$10.12 - $14.91 $533,900 - $786,606	-52,757 Reduced 5.59%	890,664 $10 Million
Q4 2022 Feb 14, 2023	SELL	$8.75 - $14.02 $4.45 Million - $7.12 Million	-508,171 Reduced 35.01%	943,421 $13.1 Million
Q3 2022 Nov 14, 2022	SELL	$7.46 - $19.28 $1.15 Million - $2.98 Million	-154,335 Reduced 9.61%	1,451,592 $16 Million
Q2 2022 Aug 15, 2022	SELL	$15.06 - $30.65 $9.72 Million - $19.8 Million	-645,545 Reduced 28.67%	1,605,927 $26 Million
Q1 2022 May 16, 2022	SELL	$23.26 - $42.41 $13.6 Million - $24.8 Million	-584,527 Reduced 20.61%	2,251,472 $65.7 Million
Q4 2021 Feb 14, 2022	SELL	$37.54 - $57.51 $1.09 Million - $1.67 Million	-29,016 Reduced 1.01%	2,835,999 $120 Million
Q3 2021 Nov 15, 2021	SELL	$45.91 - $59.67 $1.22 Million - $1.58 Million	-26,524 Reduced 0.92%	2,865,015 $143 Million
Q2 2021 Aug 16, 2021	SELL	$43.3 - $67.17 $1.59 Million - $2.46 Million	-36,681 Reduced 1.25%	2,891,539 $170 Million
Q1 2021 May 17, 2021	SELL	$44.11 - $90.64 $6.49 Million - $13.3 Million	-147,031 Reduced 4.78%	2,928,220 $171 Million
Q4 2020 Feb 16, 2021	BUY	$33.89 - $49.88 $4.26 Million - $6.27 Million	125,652 Added 4.26%	3,075,251 $143 Million
Q3 2020 Nov 16, 2020	BUY	$26.91 - $37.47 $5.84 Million - $8.13 Million	216,966 Added 7.94%	2,949,599 $99.5 Million
Q2 2020 Aug 14, 2020	SELL	$19.21 - $28.53 $7.66 Million - $11.4 Million	-398,742 Reduced 12.73%	2,732,633 $74.8 Million
Q1 2020 May 15, 2020	SELL	$11.17 - $28.72 $2.36 Million - $6.08 Million	-211,580 Reduced 6.33%	3,131,375 $57.5 Million
Q4 2019 Feb 14, 2020	SELL	$19.29 - $25.52 $1.54 Million - $2.03 Million	-79,650 Reduced 2.33%	3,342,955 $79 Million
Q3 2019 Nov 14, 2019	BUY	$21.72 - $35.38 $7.7 Million - $12.5 Million	354,437 Added 11.55%	3,422,605 $75.2 Million
Q2 2019 Aug 13, 2019	BUY	$20.59 - $35.2 $42.9 Million - $73.3 Million	2,081,581 Added 210.99%	3,068,168 $104 Million
Q1 2019 May 17, 2019	BUY	$17.28 - $25.83 $76,550 - $114,426	4,430 Added 0.45%	986,587 $25.5 Million
Q4 2018 Feb 14, 2019	BUY	$16.17 - $20.8 $257,976 - $331,843	15,954 Added 1.65%	982,157 $18 Million
Q3 2018 Oct 30, 2018	SELL	$13.39 - $22.35 $1.67 Million - $2.79 Million	-124,690 Reduced 11.43%	966,203 $20.7 Million
Q2 2018 Jul 31, 2018	BUY	$14.08 - $20.45 $5.4 Million - $7.84 Million	383,602 Added 54.24%	1,090,893 $15.7 Million
Q1 2018 Apr 30, 2018	BUY	$16.18 - $24.28 $11.4 Million - $17.2 Million	707,291 New	707,291 $12.1 Million

Others Institutions Holding QTRX

# of Institutions

155

Shares Held

33.2M

Call Options Held

30.6K

Put Options Held

25.1K

View Full List

About Quanterix Corp

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $436M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

More about QTRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account

Gilder Gagnon Howe & CO LLC Quanterix Corp Transaction History